Related Experiment Video
Updated: Apr 23, 2026
06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
6.3K
Overlap in patients with dyspepsia/functional dyspepsia
Yasuhiro Fujiwara1, Tetsuo Arakawa1
1Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Journal of Neurogastroenterology and Motility
|September 27, 2014
Summary
Patients with functional dyspepsia (FD) often have overlapping gastrointestinal and non-GI conditions. These overlaps worsen symptoms and quality of life, suggesting shared underlying causes requiring further research and treatment strategies.
Area of Science:
- Gastroenterology
- Psychiatry
- Internal Medicine
Background:
- Functional dyspepsia (FD) frequently co-occurs with other gastrointestinal (GI) and non-GI conditions.
- These overlapping conditions lead to more severe symptoms, reduced quality of life, and increased somatization.
Purpose of the Study:
- To review the epidemiology, pathogenesis, and treatment of overlapping conditions in patients with FD.
- To highlight the need for targeted research and therapeutic strategies for these complex patient cases.
Main Methods:
- Literature review of studies on overlapping conditions in functional dyspepsia.
- Analysis of epidemiological data, pathogenetic mechanisms, and existing treatment approaches.
Main Results:
- Overlap patients report more frequent/severe symptoms, poorer quality of life, and higher somatization scores.
- Increased likelihood of anxiety, depression, and insomnia in overlap patients compared to non-overlap patients.
- Common pathogenetic factors include visceral hypersensitivity, altered GI motility, infection, and early life stress.
Conclusions:
- The high prevalence of overlap in FD is not coincidental, pointing to shared underlying mechanisms.
- Current clinical trials and therapeutic strategies for overlapping conditions in FD are limited.
- Further research is crucial to understand and manage these complex patient presentations.
Related Concept Videos
01:11Pyloric Obstruction
23
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
23
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
979
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
979
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
21
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
21
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
1.1K
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K
01:28Peptic Ulcer Disease II: Pathophysiology
2.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.9K
01:24Peptic Ulcer Disease II: Pathophysiology
36
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
36